GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Common Stock

InMed Pharmaceuticals (FRA:MWG0) Common Stock : €74.16 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Common Stock?

InMed Pharmaceuticals's quarterly common stock increased from Sep. 2023 (€72.73 Mil) to Dec. 2023 (€73.30 Mil) and increased from Dec. 2023 (€73.30 Mil) to Mar. 2024 (€74.16 Mil).

InMed Pharmaceuticals's annual common stock increased from Jun. 2021 (€50.29 Mil) to Jun. 2022 (€66.90 Mil) and increased from Jun. 2022 (€66.90 Mil) to Jun. 2023 (€71.64 Mil).


InMed Pharmaceuticals Common Stock Historical Data

The historical data trend for InMed Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Common Stock Chart

InMed Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.23 47.12 50.29 66.90 71.64

InMed Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.50 71.64 72.73 73.30 74.16

InMed Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


InMed Pharmaceuticals (FRA:MWG0) Business Description

Traded in Other Exchanges
Address
815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (FRA:MWG0) Headlines

No Headlines